Daniele Pastori | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation	INTERNATIONAL JOURNAL OF CARDIOLOGY	2018
Quantifying time in atrial fibrillation and the need for anticoagulation	PROGRESS IN CARDIOVASCULAR DISEASES	2018
Reply: LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient?	JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY	2018
Reply	GASTROENTEROLOGY	2018
Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants	DATA IN BRIEF	2018
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study	INTERNAL AND EMERGENCY MEDICINE	2018
Blood hydrogen peroxide break-down activity in healthy subjects and in patients at risk of cardiovascular events	ATHEROSCLEROSIS	2018
Gut-derived lipopolysaccharides increase post-prandial oxidative stress via Nox2 activation in patients with impaired fasting glucose tolerance: effect of extra-virgin olive oil	EUROPEAN JOURNAL OF NUTRITION	2018
The intricacies of the Mediterranean diet in NAFLD. Response to Duret et al	AMERICAN JOURNAL OF GASTROENTEROLOGY	2018
Digoxin and platelet activation in patients with atrial fibrillation: In vivo and in vitro study	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2018
Remnant lipoprotein cholesterol and cardiovascular and cerebrovascular events in patients with non-alcoholic fatty liver disease	JOURNAL OF CLINICAL MEDICINE	2018
Integrated care management of patients with atrial fibrillation and risk of cardiovascular events. the abc (atrial fibrillation better care) pathway in the ATHERO-AF study cohort	MAYO CLINIC PROCEEDINGS	2018
Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician	THERAPEUTIC ADVANCES IN GASTROENTEROLOGY	2018
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants	INTERNATIONAL JOURNAL OF CARDIOLOGY	2018
Oxidative stress and cardiovascular disease: New insights	KARDIOLOGIA POLSKA	2018
Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2018
Antioxidant activity from extra virgin olive oil via inhibition of hydrogen peroxide-mediated NADPH-oxidase 2 activation	NUTRITION	2018
Progressive reduction of blood lysosomal acid lipase activity according to stage of adult chronic liver disease and altered enzymatic cellular distribution in cirrhosis	DIGESTIVE AND LIVER DISEASE	2018
Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists–naive patients with atrial fibrillation	AMERICAN HEART JOURNAL	2018
Comparison of the 2MACE and TIMI-AF scores for composite clinical outcomes in anticoagulated atrial fibrillation patients	CIRCULATION JOURNAL	2018

« prima
< precedente
…
2
3
4
5
6
7
8
9
10
11
12
13
seguente ›
ultima »

ERC

LS4
LS4_10
LS7
LS7_10

Keywords

cardiovascular disease

anticoagulation

Novel oral anticoagulants

atrial fibrillation

atherosclerosis

NAFLD

NASH

antiphospholipid antibody syndrome

ischemic heart disease

cardiovascular risk

Thrombosis

Atherothrombosis

Progetti di Ricerca

Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.